Publications

Members only publications are marked with a lock icon:
Filter By

Using Telemedicine to Assess and Manage Psychosis in Neurodegenerative Diseases in Long-Term Care

JAMDA
January 12, 2022
The coronavirus disease 2019 (COVID-19) epidemic has forced a sudden global implementation of telemedicine strategies, including in long-term care (LTC) facilities where many people with dementia and Parkinson disease (PD) reside. Telemedicine...

Factors and Outcomes Associated With Dysphagia in Hospitalized Persons With Dementia

JAMDA
January 11, 2022
Dysphagia is prevalent in older adults with dementia, particularly in the acute care setting. The objective of this study was to use an innovative approach to extract a more representative sample of patients with dysphagia from the electronic health...

An International Consensus List of Potentially Clinically Significant Drug-Drug Interactions in Older People: Clinical Utility?

JAMDA
January 10, 2022
We thank Dr Lisi for her interest in our article1 and we are pleased to provide some additional information and clarifications in relation to their comments.2

Response to “An International Consensus List of Potentially Clinically Significant Drug-Drug Interactions in Older People”

JAMDA
January 10, 2022
I commend Anrys et al1 for their attempt to develop a consensus list of potentially clinically significant drug-drug interactions (DDIs) in older people. However, there are several points that I would like to raise about this publication.

Previous SARS-CoV-2 Infection, Age, and Frailty Are Associated With 6-Month Vaccine-Induced Anti-Spike Antibody Titer in Nursing Home Residents

JAMDA
January 10, 2022
Older nursing home residents make up the population at greatest risk of morbidity and mortality from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. No studies have examined the determinants of long-term antibody responses...

MIPS 2021 Data Submission Period is Now Open

Policy Snapshot
January 7, 2022
The Centers for Medicare and Medicaid Services (CMS) has opened the data submission period for Merit-based Incentive Payment System (MIPS) eligible clinicians who participated in the 2021 performance year of the Quality Payment Program (QPP). Data...

2022 MIPS Payment Adjustments in Effect Based on 2020 Performance

Policy Snapshot
January 7, 2022
In the summer of 2021, each Merit-based Incentive Payment System (MIPS) eligible clinician received a 2020 MIPS final score and associated payment adjustment factor(s) as part of their 2020 MIPS performance feedback, available on the Quality Payment...

QPP Service Center Hold Times Expected to Increase

Policy Snapshot
January 7, 2022
The Quality Payment Program (QPP) Service Center is projecting an increase in volume of calls and emails between January and March 2022 due to the opening of the 2021 MIPS data submission period. The increase in call volume and emails will result in...

COVID-19: New HCPCS Code for Remdesivir Antiviral Medication

Policy Snapshot
January 7, 2022
Following the recent statement from the National Institutes of Health (NIH) COVID-19 Treatment Guidelines Panel regarding therapies for the COVID-19 Omicron variant, CMS created HCPCS code J0248 for VEKLURY™ (remdesivir) antiviral medication when...

SNF VBP: Nominate Technical Expert Panel Members by January 16

Policy Snapshot
January 7, 2022
CMS is creating a technical expert panel to help develop quality and cost measures for the Skilled Nursing Facility (SNF) Value-Based Purchasing (VBP) program. Nominate people to serve on the panel by January 16. Visit the Technical Expert Panels:...